Literature DB >> 32187519

Diapedesis-Induced Integrin Signaling via LFA-1 Facilitates Tissue Immunity by Inducing Intrinsic Complement C3 Expression in Immune Cells.

Martin Kolev1, Erin E West1, Natalia Kunz1, Daniel Chauss2, E Ashley Moseman3, Jubayer Rahman3, Tilo Freiwald2, Maria L Balmer4, Jonas Lötscher4, Sarah Dimeloe5, Elizabeth C Rosser6, Lucy R Wedderburn7, Katrin D Mayer-Barber8, Andrea Bohrer8, Paul Lavender9, Andrew Cope9, Luopin Wang10, Mariana J Kaplan11, Niki M Moutsopoulos12, Dorian McGavern3, Steven M Holland13, Christoph Hess14, Majid Kazemian15, Behdad Afzali16, Claudia Kemper17.   

Abstract

Intrinsic complement C3 activity is integral to human T helper type 1 (Th1) and cytotoxic T cell responses. Increased or decreased intracellular C3 results in autoimmunity and infections, respectively. The mechanisms regulating intracellular C3 expression remain undefined. We identified complement, including C3, as among the most significantly enriched biological pathway in tissue-occupying cells. We generated C3-reporter mice and confirmed that C3 expression was a defining feature of tissue-immune cells, including T cells and monocytes, occurred during transendothelial diapedesis, and depended on integrin lymphocyte-function-associated antigen 1 (LFA-1) signals. Immune cells from patients with leukocyte adhesion deficiency type 1 (LAD-1) had reduced C3 transcripts and diminished effector activities, which could be rescued proportionally by intracellular C3 provision. Conversely, increased C3 expression by T cells from arthritis patients correlated with disease severity. Our study defines integrins as key controllers of intracellular complement, demonstrates that perturbations in the LFA-1-C3-axis contribute to primary immunodeficiency, and identifies intracellular C3 as biomarker of severity in autoimmunity.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LAD-1; LFA-1; T cells; Th1 cells; autoimmunity; biomarker; complosome; integrins; intracellular complement; lymphocyte adhesion deficiency type 1; metabolism

Mesh:

Substances:

Year:  2020        PMID: 32187519      PMCID: PMC7111494          DOI: 10.1016/j.immuni.2020.02.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  71 in total

1.  A synaptic basis for paracrine interleukin-2 signaling during homotypic T cell interaction.

Authors:  Catherine A Sabatos; Junsang Doh; Sumone Chakravarti; Rachel S Friedman; Priya G Pandurangi; Aaron J Tooley; Matthew F Krummel
Journal:  Immunity       Date:  2008-07-31       Impact factor: 31.745

Review 2.  Immunological synapses within context: patterns of cell-cell communication and their application in T-T interactions.

Authors:  Junsang Doh; Matthew F Krummel
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Difference in Th1 and Th17 lymphocyte adhesion to endothelium.

Authors:  Pilar Alcaide; Elena Maganto-Garcia; Gail Newton; Richard Travers; Kevin J Croce; De-xiu Bu; Francis W Luscinskas; Andrew H Lichtman
Journal:  J Immunol       Date:  2012-01-04       Impact factor: 5.422

Review 4.  The insider's guide to leukocyte integrin signalling and function.

Authors:  Nancy Hogg; Irene Patzak; Frances Willenbrock
Journal:  Nat Rev Immunol       Date:  2011-05-20       Impact factor: 53.106

5.  Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation.

Authors:  Chintana Chirathaworn; Jacob E Kohlmeier; Scott A Tibbetts; Lisa M Rumsey; Marcia A Chan; Stephen H Benedict
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

Review 6.  T-cell activation through immunological synapses and kinapses.

Authors:  Michael L Dustin
Journal:  Immunol Rev       Date:  2008-02       Impact factor: 12.988

7.  CD46-induced immunomodulatory CD4+ T cells express the adhesion molecule and chemokine receptor pattern of intestinal T cells.

Authors:  Shannon K Alford; Gregory D Longmore; William F Stenson; Claudia Kemper
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

8.  Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells.

Authors:  John Cardone; Gaelle Le Friec; Pierre Vantourout; Andrew Roberts; Anja Fuchs; Ian Jackson; Tesha Suddason; Graham Lord; John P Atkinson; Andrew Cope; Adrian Hayday; Claudia Kemper
Journal:  Nat Immunol       Date:  2010-08-08       Impact factor: 25.606

Review 9.  A novel "complement-metabolism-inflammasome axis" as a key regulator of immune cell effector function.

Authors:  Giuseppina Arbore; Claudia Kemper
Journal:  Eur J Immunol       Date:  2016-06-08       Impact factor: 5.532

10.  Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism.

Authors:  Giuseppina Arbore; Erin E West; Jubayer Rahman; Gaelle Le Friec; Nathalie Niyonzima; Mehdi Pirooznia; Ilker Tunc; Polychronis Pavlidis; Nicholas Powell; Yuesheng Li; Poching Liu; Aude Servais; Lionel Couzi; Veronique Fremeaux-Bacchi; Leo Placais; Alastair Ferraro; Patrick R Walsh; David Kavanagh; Behdad Afzali; Paul Lavender; Helen J Lachmann; Claudia Kemper
Journal:  Nat Commun       Date:  2018-10-10       Impact factor: 14.919

View more
  19 in total

1.  TH17 cells reach fever pitch.

Authors:  Kirsty Minton
Journal:  Nat Rev Immunol       Date:  2020-04       Impact factor: 53.106

2.  Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.

Authors: 
Journal:  Sci Immunol       Date:  2021-05-13

Review 3.  Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.

Authors:  Tilo Freiwald; Behdad Afzali
Journal:  Adv Immunol       Date:  2021-11-19       Impact factor: 3.543

4.  Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation.

Authors:  Marjan Gharagozloo; Matthew D Smith; Jing Jin; Thomas Garton; Michelle Taylor; Alyssa Chao; Keya Meyers; Michael D Kornberg; Donald J Zack; Joan Ohayon; Brent A Calabresi; Daniel S Reich; Charles G Eberhart; Carlos A Pardo; Claudia Kemper; Katharine A Whartenby; Peter A Calabresi
Journal:  Acta Neuropathol       Date:  2021-09-06       Impact factor: 17.088

Review 5.  Effects of the complement system on antibody formation and function: implications for transplantation.

Authors:  Arun Cumpelik; Peter S Heeger
Journal:  Curr Opin Organ Transplant       Date:  2022-07-15       Impact factor: 2.269

Review 6.  Inside-Out of Complement in Cancer.

Authors:  Martin Kolev; Madhumita Das; Monica Gerber; Scott Baver; Pascal Deschatelets; Maciej M Markiewski
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

7.  Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging.

Authors:  Nicholas E Propson; Ethan R Roy; Alexandra Litvinchuk; Jörg Köhl; Hui Zheng
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

8.  Identification of neutrophil β2-integrin LFA-1 as a potential mechanistic biomarker in ANCA-associated vasculitis via microarray and validation analyses.

Authors:  Kotaro Matsumoto; Takahiko Kurasawa; Keiko Yoshimoto; Katsuya Suzuki; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2021-05-06       Impact factor: 5.156

Review 9.  Emerging roles of the complement system in host-pathogen interactions.

Authors:  Sanjaya K Sahu; Devesha H Kulkarni; Ayse N Ozanturk; Lina Ma; Hrishikesh S Kulkarni
Journal:  Trends Microbiol       Date:  2021-09-29       Impact factor: 17.079

10.  Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes.

Authors:  Liliana M Sanmarco; Michael A Wheeler; Cristina Gutiérrez-Vázquez; Carolina Manganeli Polonio; Mathias Linnerbauer; Felipe A Pinho-Ribeiro; Zhaorong Li; Federico Giovannoni; Katelyn V Batterman; Giulia Scalisi; Stephanie E J Zandee; Evelyn S Heck; Moneera Alsuwailm; Douglas L Rosene; Burkhard Becher; Isaac M Chiu; Alexandre Prat; Francisco J Quintana
Journal:  Nature       Date:  2021-01-06       Impact factor: 69.504

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.